[Ocriplasmin (vitreomacular traction, including when associated with macular hole) - Benefit assessment according to §35a Social Code Book V (reassessment after expiry of the decision)]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003486
German
Original Title:
Ocriplasmin (vitreomakulaere Traktion)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a18-68.html
Year Published:
2019
URL for published report:
https://www.iqwig.de/download/A18-68_Ocriplasmin_Nutzenbewertung-35a-SGB-V_V1-1.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Vitreous Detachment
- Retinal Perforations
- Fibrinolysin
- Peptide Fragments
Keywords
- Ocriplasmin
- Vitreous Detachment
- Retinal Perforations
- Benefit Assessment
- NCT00435539
- NCT00798317
- NCT00781859
- NCT01889251
- NCT01429441
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.